Abstract:Increasing evidences have indicated that only a phenotypic subset of cancer cells, termed as the cancer stem cells (CSCs), is capable of initiating tumor growth and provide a reservoir of cells that cause tumor recurrence after therapy. Epithelial–mesenchymal transition (EMT), a cell type change from an epithelial cobblestone phenotype to an elongated fibroblastic phenotype, plays a critical role not only in tumor metastasis but also in tumor recurrence and contributes to drug resistance. Accumulating evidence has shown that cells with an EMT phenotype are rich sources for CSCs, suggesting a biological link between EMT and CSCs; thus study on the link will help understand the cellular and molecular mechanisms of tumor metastasis and drug resistance. CD29 is involved in EMT through cross-talk with cadherins and CD44 has been reported as a successful used marker for CSCs. Here, we try to address whether combination of CD29 and CD44 could be used to identify cancer stem-like cells undergoing EMT in squamous cell carcinoma (SCC) and compare the molecular differences between CD29high/CD44high and CD29low/CD44low cells in SCC. Expression pattern of CD29 and CD44 was analyzed in tissues of skin SCC and cultured A431 cells by immunostaining. Subtype cells of CD29high/CD44high and CD29low/CD44low A431 were sorted by fluorescence-activated cell sorting and proliferating abilities were assayed by cell counting, colony forming and tumorigenicity in NOD/SCID mice. Finally, to probe more deeply into the molecular differences between CD29high/CD44high and CD29low/CD44low A431 cells, gene microarray analysis was applied to compare gene expression profiling. Staining of CD29 and CD44 showed similar heterogeneous expression pattern with positive cells located in the invasion front of SCC tissue as well as in cultured A431 cells. Sorted CD29high/CD44high A431 cells had higher proliferating ability in vitro and in NOD/SCID mice as compared with CD29low/CD44low cells. Gene profiling identified differentiated gene expressions between CD29high/CD44high and CD29low/CD44low A431 cells. These genes are involved in cell cycle, cell malignant transformation, metastasis, drug resistance and EMT, implying that CD29high/CD44high cells have properties of CSCs and EMT. Our present results demonstrated heterogeneous gene expression patterns and different biological behavior in SCC. Combination of CD29 and CD44 can be used as markers to enrich CSCs in human SCC. Moreover, CD29high/CD44high cells exhibit molecular characteristics of EMT, suggesting that CSC-associated pathways were involved in EMT. Studies on correlation of CSCs and the cells undergoing EMT may explain some aspects of tumor progression and drug resistance.

[Expression of integrin beta1 in squamous cell carcinoma].

Expression of Integrinβ1 in Squamous Cell Carcinoma

Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 in Vulvar Squamous Cell Carcinoma and Its Effect on the Biological Behavior of A-431 Cells

Expression and Significance of Integrins Subunits in Laryngeal Squamous Cell Carcinoma

Immunolocalization of Vimentin, Keratin 17, Ki-67, Involucrin, β-Catenin and E-Cadherin in Cutaneous Squamous Cell Carcinoma

Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Integrins and basement membrane proteins in skin carcinomas

Cancer Stem-Like Cells Enriched with CD29 and CD44 Markers Exhibit Molecular Characteristics with Epithelial–mesenchymal Transition in Squamous Cell Carcinoma

The clinical significance and potential molecular mechanism of integrin subunit beta 4 in laryngeal squamous cell carcinoma

[Expression of Notch1 and Epidermal Growth Factor Receptor in Human Tongue Squamous Cell Carcinoma and Precancerous Lesion].

Integrins in cancer stem cells

Significant Role of Collagen XVII And Integrin β4 in Migration and Invasion of The Less Aggressive Squamous Cell Carcinoma Cells

Clinical Significance of Integrin Subunit Beta 4 in Head and Neck Squamous Cell Carcinoma

Expression of Differentiation Associated Protein Hes1 and Hes5 in Cervical Squamous Carcinoma and Its Precursors.

Expressions and significance of integrin β4 and S100A4 in different molecular subtypes of invasive ductal carcinoma of breast

Correlation Between Integrin A5,β1 Subunit Expression in Bladder Transitional Cell Carcinoma and Its Clinical Implication

Expression and clinical significance of integrin α_3β_1 and MMP-7 expression in esophageal squamous cell carcinoma

Integrin αvβ5 as a biomarker for the assessment of non-small cell lung cancer metastasis and overall survival.

[Correlation Between Integrin Subunits Alpha5 and Beta1 Expressions in Prostate Cancer and Its Clinical Implication].

Beta-Catenin Expression Pattern in Primary Oral Squamous Cell Carcinoma

The characteristics and the multiple functions of integrin β1 in human cancers